Zhejiang Hichi Pharmaceutical Co., Ltd. (referred to as “Haichang Pharmaceutical”) has passed the GMP compliance inspection in the third workshop for the synthesis of APIs (iohexol), the fine drying workshop and the production line 1.

With the gradual release of the production capacity of iohexol raw materials and the increase in sales scale, the company’s operating conditions will also be improved, which will play a positive role in promoting the company’s stable development in the future.